Jensen-Salsbery Laboratories, Inc. v. O. M. Franklin Blackleg Serum Co.

72 F.2d 15, 22 U.S.P.Q. (BNA) 137, 1934 U.S. App. LEXIS 4431
CourtCourt of Appeals for the Tenth Circuit
DecidedJune 30, 1934
Docket1013
StatusPublished
Cited by26 cases

This text of 72 F.2d 15 (Jensen-Salsbery Laboratories, Inc. v. O. M. Franklin Blackleg Serum Co.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jensen-Salsbery Laboratories, Inc. v. O. M. Franklin Blackleg Serum Co., 72 F.2d 15, 22 U.S.P.Q. (BNA) 137, 1934 U.S. App. LEXIS 4431 (10th Cir. 1934).

Opinion

PHILLIPS, Circuit Judge.

The O. M. Franklin Blackleg Serum Company, hereinafter called Franklin Company, brought this suit against the Jensen-Saisbery Laboratories, Ine., hereinafter called JensenSaisbery, to enjoin infringement of patent No. 1,511,557, issued October 14, 1934, and for an accounting.

The patent is for a process for preparing blackleg bacterin. It is a vaccine used to immunize against symptomatic anthrax or blackleg, a disease to which herbivorous animals, chiefly cattle and sheep, are subject.

The process of the patent consists of three steps:

(1) A suitable liquid medium is obtained by grinding a meat substance and extracting the broth therefrom. Salt and peptone are added. Calcium carbonate and starch inclosed in a muslin sack a,re placed in this liquid medium, and it is sterilized.

(3) The medium is then inoculated with a freshly isolated culture of Clostridium chauvei, the bacilli which cause blackleg, and the bacteria are grown in the liquid medium. After suitable growth the medium is strained through cotton or fine wire gauze to remove the coarser particles. A formalin solution is then added and the medium, maintained at a temperature of about 45° C. for several days. The bacteria are thus killed without destroying their antigenic or immunizing properties.

*16 (3) The resultant product is then treated to obtain the micro-organisms in suitable form for use as a bacterin.

As to such treatment the specification, after describing steps one and two, states:

“After the foregoing treatment, the culture is allowed to settle, most of the organisms settling out in a short time. The product is then treated in any suitable way to obtain the organisms in a form for use as a vaccine or baeterin. * * * One method of procedure is to decant the supernatant liquid to about lyiOth of its original volume, the remaining liquid containing the organisms being' used as a vaccine. An alternative procedure is to centrifuge the organisms out of the media and dry them. The dry powder thus obtained is used for direct injection as a vaccine by suspending the same in suitable liquid suspension or, if desired, the dry powder can be made in the form of a pellet and used as a vaccine.”

Claims 1 and 2 may be regarded as typical of the claims here involved. They read as follows:

“1. The method of preparing a blackleg vaccine which consists in growing blackleg organisms in a suitable culture media, adding a reagent to kill the organisms without destroying their antigenic properties, and treating the resultant product to obtain the organisms in suitable form for immunizing use.
“2. The method of preparing a blackleg vaccine which consists in growing blackleg organisms in a suitable culture media, treating the same- after suitable growth with a formalin solution in a concentration sufficient to kill the organisms without destroying their antigenic properties, and treating the resulting product to obtain the organisms in suitable form for immunizing use.”

Claims 3 to 9, inclusive, are set out in note 1 .

The material portions of the specification are set out in note 2 .

*17 The file wrapper discloses that original claim 2 read as follows:

“In a method of making blackleg vaccine, the steps which consist in inoculating into a suitable media a culture of blackleg organisms, treating the culture after suitable growth with a formalin solution and heating tho product to a temperature not exceeding 50° C. whereby the organisms are killed but retain immunizing properties.”

It will be noted that this claim is for a two-step process. Original claims 1, and 3 to 9, inclusive, covered a three-step process. Original claims 1 to 9 were rejected.

Claim 2 was then amended by inserting before the word “media” the word “liquid,” and following the word “media” the phrase, “substantially free from solid matter.” Like amendments were made to claims 1, and 3 to 7, inclusive, which still covered the three-step process.

A new claim 8, to take the place of original claims 8 and 9, was submitted. It read as follows:

“The method of preparing a blackleg vaccine, which consists in growing in a suitable liquid media under aerobic conditions a culture of blackleg organisms, adding to the culture after suitable growth a reagent to kill the organisms, heating the same to a lempera.ture not exceeding .j0'° 0. and treating the resultant product to obtain the organisms in suitable form Cor immunizing use.”

Amended claims 1 to 8, inclusive, were rejected. They were then canceled, and claims 1 to 9 of the patent in suit were applied for and allowed.

Jensen-Salsbery prepares blackleg bacteria by a process consisting of two steps: (1) Growing the micro -organisms in a suitable culture medium, and (2) killing the microorganisms with a reagent and heat. It does not employ any treatment to obtain the microorganisms in a suitable form for immunizing use by decanting- the supernatant liquid, or by centrifuging the micro-organisms and drying them, or any other similar treatment. It simply subjects the product resulting from the two-step process to the test required by the Department of Agriculture, and if it meets that test it places it in containers and distributes it for immunizing use.

The cause was submitted to a special master. In his report the master states:

“Does the addition of this admittedly non-essential statement and unpatentable third step in the patent, so differentiate plaintiff’s process from defendant’s process in making the same immunizing product, as to avoid infringement?”

The master states that the novelty of the invention lies in the discovery by Franklin that the micro-organisms could be killed with formalin without destroying their antigenic properties; that the third step was non-essential, and that there was no substantial or *18 essential difference between the process of the patent and the process employed by JensenSalsbery.

He found claims 1 to 9 valid and infringed, and recommended a decree accordingly.

From a decree confirming the master’s report, adjudging claims 1 to 9 valid and infringed and directing an accounting, JensenSalsbery has appealed.

Where an applicant for a patent on a mechanical combination or a process is compelled by the rejection of his application by the Patent Office to narrow his claim by the introduction of a new element in the combination or a new step in the process, he cannot, after the issue of the patent, broaden his claim by omitting the element or step he was compelled to include in order to secure his patent. If dissatisfied with the rejection, he should appeal therefrom, and where, in order to get his patent, he accepts one with a narrower claim, he is bound by it.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Petersen v. Fee International, Ltd.
381 F. Supp. 1071 (W.D. Oklahoma, 1974)
Sears, Roebuck & Co. v. Jones
308 F.2d 705 (Tenth Circuit, 1962)
Zenith Radio Corp. v. Lehman
121 F. Supp. 69 (S.D. New York, 1954)
Darsyn Laboratories, Inc. v. Lenox Laboratories, Inc.
120 F. Supp. 42 (D. New Jersey, 1954)
Harris v. National MacHine Works, Inc.
171 F.2d 85 (Tenth Circuit, 1948)
Interstate Bakeries v. General Baking Co.
84 F. Supp. 92 (D. Kansas, 1948)
Holmes v. Atlas Garage Door Co.
63 F. Supp. 692 (S.D. California, 1945)
De Cew v. Union Bag & Paper Corp.
59 F. Supp. 301 (D. New Jersey, 1945)
Band-It Co. v. McAneny
131 F.2d 766 (Tenth Circuit, 1942)
Texas Co. v. Anderson-Prichard Refining Corporation
122 F.2d 829 (Tenth Circuit, 1941)
Etten v. Kauffman
121 F.2d 137 (Third Circuit, 1941)
Texas Co. v. Anderson-Prichard Refining Corp.
32 F. Supp. 347 (W.D. Oklahoma, 1940)
American Seating Co. v. Ideal Seating Co.
32 F. Supp. 169 (W.D. Michigan, 1940)
Haynes Stellite Co. v. Osage Metal Co.
110 F.2d 11 (Tenth Circuit, 1939)
American Laundry Mach. Co. v. Strike
103 F.2d 453 (Tenth Circuit, 1939)
Tschappat v. Hinderliter Tool Co.
98 F.2d 994 (Tenth Circuit, 1938)
Steiner Sales Co. v. Schwartz Sales Co.
98 F.2d 999 (Tenth Circuit, 1938)
Oliver United Filters, Inc. v. Eimco Corp.
91 F.2d 345 (Tenth Circuit, 1937)
Gasoline Products Co. v. Champlin Refining Co.
86 F.2d 552 (Tenth Circuit, 1936)

Cite This Page — Counsel Stack

Bluebook (online)
72 F.2d 15, 22 U.S.P.Q. (BNA) 137, 1934 U.S. App. LEXIS 4431, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jensen-salsbery-laboratories-inc-v-o-m-franklin-blackleg-serum-co-ca10-1934.